Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Hommes

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Expert Opinion on Biological Therapy|August 21, 2007
Biologics in Crohn's disease: searching indicators for outcomeC Janneke van der Woude, Daniel W Hommes
Gastroenterology|May 29, 2004
Endoscopy in inflammatory bowel diseasesDaniel W Hommes, Sander J H van Deventer
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Are we ready for top-down therapy for inflammatory bowel diseases: proC Janneke van der Woude, Daniel W Hommes
Current Opinion in Gastroenterology|May 14, 2013
Stem cell therapy in inflammatory bowel disease: which, when and how?Welmoed K van Deen, Angelos Oikonomopoulos, Daniel W Hommes
Molecular and Cellular Endocrinology|July 17, 2007
Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonistsCindy Stahn, Mark Löwenberg, Daniel W Hommes, et al.
Best Practice & Research. Clinical Gastroenterology|May 6, 2009
Update on genetics in inflammatory diseaseCasper G Noomen, Daniel W Hommes, Herma H Fidder
Steroids|January 29, 2008
Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligandsMark Löwenberg, Cindy Stahn, Daniel W Hommes, et al.
Journal of Crohn'S & Colitis|February 18, 2015
Value-based health care for inflammatory bowel diseasesWelmoed K van Deen, Eric Esrailian, Daniel W Hommes
Current Drug Targets|May 1, 2013
Anti-TNF antibodies in inflammatory bowel disease: do we finally know how it works?Angelos Oikonomopoulos, Welmoed K van Deen, Daniel W Hommes
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2006
Pharmacogenomics in inflammatory bowel diseaseLaurence J Egan, Luc J J Derijks, Daniel W Hommes
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Expert Opinion on Biological Therapy|August 21, 2007
Biologics in Crohn's disease: searching indicators for outcomeC Janneke van der Woude, Daniel W Hommes
Gastroenterology|May 29, 2004
Endoscopy in inflammatory bowel diseasesDaniel W Hommes, Sander J H van Deventer
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Are we ready for top-down therapy for inflammatory bowel diseases: proC Janneke van der Woude, Daniel W Hommes
Current Opinion in Gastroenterology|May 14, 2013
Stem cell therapy in inflammatory bowel disease: which, when and how?Welmoed K van Deen, Angelos Oikonomopoulos, Daniel W Hommes
Molecular and Cellular Endocrinology|July 17, 2007
Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonistsCindy Stahn, Mark Löwenberg, Daniel W Hommes, et al.
Best Practice & Research. Clinical Gastroenterology|May 6, 2009
Update on genetics in inflammatory diseaseCasper G Noomen, Daniel W Hommes, Herma H Fidder
Steroids|January 29, 2008
Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligandsMark Löwenberg, Cindy Stahn, Daniel W Hommes, et al.
Journal of Crohn'S & Colitis|February 18, 2015
Value-based health care for inflammatory bowel diseasesWelmoed K van Deen, Eric Esrailian, Daniel W Hommes
Current Drug Targets|May 1, 2013
Anti-TNF antibodies in inflammatory bowel disease: do we finally know how it works?Angelos Oikonomopoulos, Welmoed K van Deen, Daniel W Hommes
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2006
Pharmacogenomics in inflammatory bowel diseaseLaurence J Egan, Luc J J Derijks, Daniel W Hommes
Pageof 13